Neutrahealth Annual Report and Accounts

Date : 06/26/2008 @ 5:04AM
Source : UK Regulatory (RNS and others)
Stock : Neutrahealth Plc (NUT)
Quote : 2.5  0.0 (0.00%) @ 2:47AM
<< BackQuote Chart

 



Neutrahealth Annual Report and Accounts

    RNS Number : 5891X
  NeutraHealth Plc
  26 June 2008
   


    NEUTRAHEALTH PLC ("the Company")

    The Company announces that is has posted its annual report and account to shareholders and
that these may also be viewed on the
Company's website: www.neutrahealthplc.com"

    For more information:
    Further information for investors is available on the Company's website at
www.neutrahealthplc.com/

 NeutraHealth plc
 Michael Toxvaerd, Deputy Chairman      07730 581 584
 Robin Hilton, Finance Director         07738 018 411

 Cenkos (Nominated Adviser and Broker)
 Stephen Keys                           020 7397 8900



    Notes:
    NeutraHealth was floated on AIM in February 2005 with the strategy of consolidating the
fragmented Vitamins, Minerals and Supplements
sector of the growing nutraceutical market. The company is focused on building a group of
companies within the nutraceutical market which
will deliver growth through organic expansion and through strategic acquisitions.

    The company made its first acquisition, BioCare, in August 2005 for £16.1m, and has made
three subsequent acquisitions. Recent events
include:



    January 2007
    *     Acquisition for £4.0m of Brunel Healthcare Limited, an established supplier of
nutraceutical products and over the counter
medicines sold by major retailers across the UK.

    April 2007
    *     Signed three year agreement with the UK's leading high street retailer of vitamins,
minerals and supplements to continue to supply
products under private label until at least August 2010, contractually underpinning 20% of
current group sales

    July 2007
    *     Acquisition of Health Products for Life for £0.4m, a direct to consumer website 
    *     Signing of licensing agreement with leading nutrition expert Patrick Holford

    August 2007
    *     Net £5.3 million investment in 20% of NeutraHealth by Elder Pharmaceuticals Limited
of India through issue of shares at 16p
    *     Investment made at a 36% premium to mid-market price on day of announcement
    *     Funds raised for future acquisitions, and opportunities for distribution and
manufacturing between businesses

    January 2008
    *     Acquisition of Galloways and Gerard House brands and herbal licenses for £0.4m



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
ACSFKAKKCBKKDAB
<< Back


Neutrahealth Plc Historical Chart Neutrahealth Plc Intraday Chart  
Period
noad


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
38 site:2us 081204 20:00 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )